Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Strides announces Q4FY20 and FY20 Financial results

Posted On: 2020-05-20 22:36:19

Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) today announced its Q4 and FY20 results.

- Reports strong performance in FY20 despite Ranitidine withdrawal from the US market
- Adjusted FY20 revenues at Rs. 29,127 million with 33% YoY growth, Reported revenues grew by 26%
- FY20 Adjusted EBITDA at Rs. 6,514 million, translating into 22.4% EBITDA margins and YoY growth of 153%
- Reported EBITDA at Rs. 5,276 million delivering 19.1% EBITDA margins and 105% YoY growth
- Regulated markets clocked 47% revenue growth in FY20
- US business meets higher end of FY20 guidance
- Adjusted for Ranitidine withdrawal, Q4FY20 performance in line with expectation
- Recommends dividend of Rs. 2/- per share resulting in the total dividend for the year at Rs. 14/- per share (140%)

Commenting on the performance, Dr R Ananthanarayanan, CEO & MD, remarked, "The financial year 2020 has met all strategic and financial outcomes for Strides in spite of the unexpected US FDA direction to withdraw Ranitidine on the last day of FY20. While we have grown our revenues by 26% (33% Adjusted), our EBITDA has grown over two times, demonstrating over 740 basis point (1,070 basis point Adjusted) improvement in the margins. We are also satisfied that the regulated markets continued its healthy track record and our US business met the upper end of our FY20 outlook, including the revenues from Ranitidine.

We have entered into a new world order with Covid-19, the magnitude and scale of which remains indeterminate. We have maintained our agility and responsiveness to deal with this situation and are pursuing our commitment to 3Ps viz- Patients, People and Purpose. We are determined to play a substantial role in society by bringing affordable and quality healthcare to millions of people around the globe. We strongly believe that our businesses will maintain traction and would grow significantly to culminate into a healthy financial outcome for Strides in FY21."

Shares of Strides Pharma Science Ltd was last trading in BSE at Rs.421.05 as compared to the previous close of Rs. 414.65. The total number of shares traded during the day was 237320 in over 5057 trades.

The stock hit an intraday high of Rs. 432.25 and intraday low of 414.75. The net turnover during the day was Rs. 100218281.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Vaibhav Global Ltd board recommends final dividend of Rs. 7 for FY20

Vaibhav Global Ltd Q4 FY20 consolidated PAT at Rs. 39.73 crore

TATA Investment Corporation Ltd reports consolidated loss of Rs. 36.26 crore in Q4 FY20

IndoStar announces completion of equity raise of INR 1,225 crore from Brookfield

Quess Corp - Navigating successfully in turbulent times

Oil India Ltd - Blowout at Baghjan Well No 5

Foseco India Ltd Q1 CY2020 PAT at Rs. 6.08 crore

United Spirits Ltd reports consolidated PAT of Rs. 58.4 crore in Q4 FY2020

Ujjivan Financial Services Ltd posts Q4 FY20 consolidated PAT of Rs. 64.03 crore

Gujarat Pipavav Port Ltd Board to consider FY20 results & Final Dividend on June 09, 2020

PCBL Senior Leadership Team leads in voluntary pay cut

Sun Pharma reports Q4FY20 results

IndiGrid reports 92% jump YoY in its consolidated revenue for Q4

Aditya Birla Fashion and Retail Ltd reports earnings for Q4, FY2020

Wipro Gallagher Solutions Launches NetOxygen Loan Origination Solution (LOS) Version 7.0

StackRoute announces job-linked 'Post Graduate Program in Full Stack Product Engineering' for Fresh Engineering Graduates and Young Professionals

Compucom Software Ltd board recommends Final Dividend of Rs. 0.30

Tube Investments of India Ltd standalone Q4 PBT before exceptional items up by 26%

Ujjivan Financial Services Ltd board recommends dividend of Rs. 0.80

Vedanta - VGCB continues to scale-up community outreach activities to combat COVID-19 Pandemic

Aditya Birla Fashion and Retail Ltd Board approves Rs. 1000 crore Rights Issue of equity shares

TATA Investment Corporation Ltd Board approves dividend of Rs. 18 for FY2020

Dabur India Ltd Board recommends Final Dividend of Rs. 1.60

First Virtual listing ceremony of Mitsu Chem Plast Ltd. on BSE Mainboard

Heritage Foods Limited Board recommends Dividend of Rs. 2.50 for FY20

D2H launches DIA, an AI-enabled chatbot for customer service

U GRO appoints Global Value Creation Partners to support its development as a premier impact financing platform for MSMEs

IDFC FIRST Bank launches video KYC for online Savings Accounts

Tube Investments of India Limited board skips final dividend

Sun Pharmaceutical Industries Ltd Board approves final dividend of Rs. 1 for FY2020

Aditya Birla Fashion and Retail Limited board approves fund raising of Rs. 1000 crore

DABUR India Ltd posts lower consolidated PAT of Rs. 281.17 crore in Q4 FY20

Sun Pharmaceutical Industries Ltd reports Rs. 399.84 crore consolidated PAT in Q4 FY20

KPIT Technologies Ltd consolidated Q4 net profit at Rs. 37.13 crore

Saksoft Ltd consolidated Q4 FY2020 net profit at Rs. 9.79 crore

JSW Holdings Ltd Q4 consolidated PAT up at Rs. 9.60 crore

Beardsell Ltd board approves 1:3 rights issue

Manappuram Finance Ltd approves issue of NCDs of Rs. 500 crore

TCS iON Readies Exam Centers to Operate with Social Distancing and Hygiene Norms Post Lockdown

TIMKEN India Ltd board to approve quarterly results on June 5, 2020

Relaxo Footwears Ltd board to consider FY20 results, final dividend on June 6, 2020

Tamboli Capital Ltd board to announce FY20 results, dividend on June 13, 2020

Indian Oil Corporation Ltd allots NCDs of Rs. 3000 crore

Sagarsoft (India) Ltd board recommends dividend of Rs. 1.50

Zydus Wellness Ltd board to approve Q4, FY20 results on June 2, 2020

Indostar Capital Finance Ltd allots securities to BCP V Multiple Holdings Pte. Ltd

Aurobindo Pharma Ltd board to consider 4th quarter results on June 3, 2020

Adani Ports and Special Economic Zone Limited raises Rs. 700 crores through NCDs

TCS a Leader and Star Performer in Property & Casualty Insurance BPO Services: Everest Group

Future Retail Ltd board approves raising of upto Rs. 650 crore through NCDs

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019